drugset / Trial / NCT00236743

A Study of the Effectiveness and Safety of Topiramate in the Treatment of Children With Epilepsy

NCT00236743

RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to evaluate the safety and effectiveness of oral topiramate as add-on therapy in children with uncontrolled partial onset seizures who are taking one or two standard anti-epileptic drugs.

Timeline

Start
1994-06
Primary completion
Completion
2000-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Topiramate Small molecule 125 mg Oral
Subject Topiramate Small molecule 175 mg Oral
Subject Topiramate Small molecule 225 mg Oral
Subject Topiramate Small molecule 400 mg Oral

Indications